<p>Potential role of the antimicrobial peptide <em>Tachyplesin III</em> against multidrug-resistant <em>P. aeruginosa</em> and <em>A. baumannii</em> coinfection in an animal model</p>

Abstract

Therefore, our study demonstrated that <i>Tachyplesin III</i> represents a potential therapeutic treatment against mixed-MDR bacterial infection in vivo, which sheds light on the development of therapeutic strategies against mixed-MDR bacterial infections.